Finance

Senarai
2096:HKG
Simcere Pharmaceutical Group Ltd
HK$11.02
+1.75%
(+0.19) 1H
16 Okt, 4:08:14 PTG GMT+8  ·   HKD
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk 2096...
Buka
HK$10.85
Tinggi
HK$11.29
Rendah
HK$10.85
Permodalan Pasaran
28.30B
Purata volum
4.02J
Volum
5.80J
Dividen
1.88%
Dividen suku tahunan
HK$0.05
Tarikh tanpa dividen
18 Jun 2025
Nisbah H/P
16.54
tgi 52 mgu
HK$14.38
rdh 52 mgu
HK$9.07
EPS
HK$0.67
Syer tertunggak
2.57B
Bilangan pekerja
7K
Buka
HK$10.85
Tinggi
HK$11.29
Rendah
HK$10.85
Permodalan Pasaran
28.30B
Purata volum
4.02J
Volum
5.80J
Dividen
1.88%
Dividen suku tahunan
HK$0.05
Tarikh tanpa dividen
18 Jun 2025
Nisbah H/P
16.54
tgi 52 mgu
HK$14.38
rdh 52 mgu
HK$9.07
EPS
HK$0.67
Syer tertunggak
2.57B
Bilangan pekerja
7K
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Simcere Pharmaceutical Group or Simcere Pharmaceutical is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration to manufacture and sell over 210 other products. Wikipedia
Perihal Simcere Pharmaceutical Group Ltd
CEORen Jinsheng
Pekerja7.06K
Diasaskan1995
Ibu pejabatNanjing, Jiangsu, China
Sektor-
Laman websimcere.com
Laporan sebelumnya
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam CNY
Sep 2025
Dis 2025
Mac 2026
Jun 2026
Hasil
2.07B
2.07B
2.29B
2.29B
Kos barangan yang dijual
365.25J
365.25J
382.55J
382.55J
Kos hasil
365.25J
365.25J
382.55J
382.55J
Perbelanjaan penyelidikan dan pembangunan
465.30J
465.30J
412.46J
412.46J
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
949.52J
949.52J
1.01B
1.01B
Belanja kendalian
1.36B
1.36B
1.39B
1.39B
Jumlah belanja kendalian
1.72B
1.72B
1.77B
1.77B
Pendapatan kendalian
351.33J
351.33J
520.99J
520.99J
Pendapatan bukan kendalian lain
-
-
-
-
EBT termasuk item luar biasa
425.92J
425.92J
483.36J
483.36J
EBT tidak termasuk item luar biasa
348.89J
348.89J
531.61J
531.61J
Belanja cukai pendapatan
55.72J
55.72J
70.09J
70.09J
Kadar cukai berkesan
13.08%
13.08%
14.50%
14.50%
Belanja kendalian lain
-56.27J
-56.27J
-42.94J
-42.94J
Pendapatan bersih
370.20J
370.20J
414.36J
414.36J
Margin untung bersih
17.86%
17.86%
18.09%
18.09%
Perolehan bagi setiap syer
-
-
-
-
Pendapatan faedah dan pelaburan
14.60J
14.60J
24.20J
24.20J
Belanja faedah
-23.63J
-23.63J
-24.61J
-24.61J
Belanja faedah bersih
-9.03J
-9.03J
-416.00K
-416.00K
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
449.72J
449.72J
606.04J
606.04J
Keuntungan atau kerugian daripada jualan aset
-115.50K
-115.50K
-
-
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google